Psychemedics Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 22.1 million compared to USD 25.24 million a year ago. Net loss was USD 4.15 million compared to USD 1.08 million a year ago.

Basic loss per share from continuing operations was USD 0.72 compared to USD 0.19 a year ago. Diluted loss per share from continuing operations was USD 0.72 compared to USD 0.19 a year ago.